Analyst Ratings for Eli Lilly (LLY) [Buys]
LLY Rating Summary
LLY Price Target Summary
- Highest: $722.00 (Morgan Stanley)
- Lowest: $270.00 (Atlantic Equities)
- Average: $580.95
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$580.95 (-2.9%)
* Over Last 12-Mos
Rating Score: 7.3 / 10
Percentile Rank: 78%
Avg. $ Target:
$580.95 (-2.9%)
* Over Last 12-Mos
Rating Score: 7.3 / 10
Percentile Rank: 78%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/20/2023 | UBS | Trung Huynh | New Coverage | Buy (N/A) |
710.00 (612.00) |
607.24 (598.05) |
-1.51% | Details |
| 9/15/2023 | CFRA | N/A | Downgrade | Buy (Strong Buy) |
634.00 (N/A) |
591.61 (598.05) |
1.09% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
